i
Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
-
Aug 2005
-
-
Source: Emerg Infect Dis. 11(8):1280-1282.
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:We analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts.
-
Subjects:
-
Source:
-
Document Type:
-
Name as Subject:
-
Place as Subject:
-
Location:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: